Robert L Hanson1, Saied Safabakhsh2, Jeffrey M Curtis3, Wen-Chi Hsueh3, Lois I Jones3, Tanisha F Aflague2, Jenny Duenas Sarmiento2, Satish Kumar4,5, Nicholas B Blackburn4,5, Joanne E Curran4,5, Darin Mahkee3, Leslie J Baier3, William C Knowler3, Robert G Nelson3. 1. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 E. Indian School Road, Phoenix, AZ, 85014, USA. rhanson@phx.niddk.nih.gov. 2. Micronesian Institute for Disease Prevention and Research, Sinajana, Guam. 3. Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, 1550 E. Indian School Road, Phoenix, AZ, 85014, USA. 4. South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA. 5. Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA.
Abstract
AIMS/HYPOTHESIS: Variants in CREBRF (rs12513649 and rs373863828) have been strongly associated with increased BMI and decreased risk of type 2 diabetes in Polynesian populations; the A allele at rs373863828 is common in Polynesians but rare in most other global populations. The aim of the present study was to assess the association of CREBRF variants with obesity and diabetes in Pacific Islander (largely Marianas and Micronesian) populations from Guam and Saipan. METHODS: CREBRF rs12513649 and rs373863828 were genotyped in 2022 participants in a community-based cross-sectional study designed to identify determinants of diabetes and end-stage renal disease (ESRD). Associations were analysed with adjustment for age, sex, ESRD and the first four genetic principal components from a genome-wide association study (to account for population stratification); a genomic control procedure was used to account for residual stratification. RESULTS: The G allele at rs12513649 had an overall frequency of 7.7%, which varied from 2.2% to 20.7% across different Marianas and Micronesian populations; overall frequency of the A allele at rs373863828 was 4.2% (range: 1.1-5.4%). The G allele at rs12513649 was associated with higher BMI (β = 1.55 kg/m2 per copy; p = 0.0026) as was the A allele at rs373863828 (β = 1.48 kg/m2, p = 0.033). The same alleles were associated with lower risk of diabetes (OR per copy: 0.63 [p = 0.0063] and 0.49 [p = 0.0022], respectively). Meta-analyses combining the current results with previous results in Polynesians showed a strong association between the A allele at rs373863828 and BMI (β = 1.38 kg/m2; p = 2.5 × 10-29) and diabetes (OR 0.65, p = 1.5 × 10-13). CONCLUSIONS/ INTERPRETATION: These results confirm the associations of CREBRF variants with higher BMI and lower risk of diabetes and, importantly, they suggest that these variants contribute to the risk of obesity and diabetes in Oceanic populations.
AIMS/HYPOTHESIS: Variants in CREBRF (rs12513649 and rs373863828) have been strongly associated with increased BMI and decreased risk of type 2 diabetes in Polynesian populations; the A allele at rs373863828 is common in Polynesians but rare in most other global populations. The aim of the present study was to assess the association of CREBRF variants with obesity and diabetes in Pacific Islander (largely Marianas and Micronesian) populations from Guam and Saipan. METHODS:CREBRFrs12513649 and rs373863828 were genotyped in 2022 participants in a community-based cross-sectional study designed to identify determinants of diabetes and end-stage renal disease (ESRD). Associations were analysed with adjustment for age, sex, ESRD and the first four genetic principal components from a genome-wide association study (to account for population stratification); a genomic control procedure was used to account for residual stratification. RESULTS: The G allele at rs12513649 had an overall frequency of 7.7%, which varied from 2.2% to 20.7% across different Marianas and Micronesian populations; overall frequency of the A allele at rs373863828 was 4.2% (range: 1.1-5.4%). The G allele at rs12513649 was associated with higher BMI (β = 1.55 kg/m2 per copy; p = 0.0026) as was the A allele at rs373863828 (β = 1.48 kg/m2, p = 0.033). The same alleles were associated with lower risk of diabetes (OR per copy: 0.63 [p = 0.0063] and 0.49 [p = 0.0022], respectively). Meta-analyses combining the current results with previous results in Polynesians showed a strong association between the A allele at rs373863828 and BMI (β = 1.38 kg/m2; p = 2.5 × 10-29) and diabetes (OR 0.65, p = 1.5 × 10-13). CONCLUSIONS/ INTERPRETATION: These results confirm the associations of CREBRF variants with higher BMI and lower risk of diabetes and, importantly, they suggest that these variants contribute to the risk of obesity and diabetes in Oceanic populations.
Entities:
Keywords:
CREBRF; Genetics; Marianas; Micronesians; Obesity; Type 2 diabetes mellitus
Authors: William C Knowler; Josef Coresh; Robert C Elston; Barry I Freedman; Sudha K Iyengar; Paul L Kimmel; Jane M Olson; Rosemarie Plaetke; John R Sedor; Michael F Seldin Journal: J Diabetes Complications Date: 2005 Jan-Feb Impact factor: 2.852
Authors: Mohanraj Krishnan; Tanya J Major; Ruth K Topless; Ofa Dewes; Lennex Yu; John M D Thompson; Lesley McCowan; Janak de Zoysa; Lisa K Stamp; Nicola Dalbeth; Jennie Harré Hindmarsh; Nuku Rapana; Ranjan Deka; Winston W H Eng; Daniel E Weeks; Ryan L Minster; Stephen T McGarvey; Satupa'itea Viali; Take Naseri; Muagututi'a Sefuiva Reupena; Phillip Wilcox; David Grattan; Peter R Shepherd; Andrew N Shelling; Rinki Murphy; Tony R Merriman Journal: Diabetologia Date: 2018-05-02 Impact factor: 10.122
Authors: Ryan L Minster; Nicola L Hawley; Chi-Ting Su; Guangyun Sun; Erin E Kershaw; Hong Cheng; Olive D Buhule; Jerome Lin; Muagututi'a Sefuiva Reupena; Satupa'itea Viali; John Tuitele; Take Naseri; Zsolt Urban; Ranjan Deka; Daniel E Weeks; Stephen T McGarvey Journal: Nat Genet Date: 2016-07-25 Impact factor: 38.330
Authors: Lindsay Fernández-Rhodes; Kristin L Young; Adam G Lilly; Laura M Raffield; Heather M Highland; Genevieve L Wojcik; Cary Agler; Shelly-Ann M Love; Samson Okello; Lauren E Petty; Mariaelisa Graff; Jennifer E Below; Kimon Divaris; Kari E North Journal: Circ Res Date: 2020-06-04 Impact factor: 17.367
Authors: Hannah J Burden; Shannon Adams; Braydon Kulatea; Morag Wright-McNaughton; Danielle Sword; Jennifer J Ormsbee; Conor Watene-O'Sullivan; Tony R Merriman; Jennifer L Knopp; J Geoffrey Chase; Jeremy D Krebs; Rosemary M Hall; Lindsay D Plank; Rinki Murphy; Peter R Shepherd; Troy L Merry Journal: Diabetologia Date: 2021-08-21 Impact factor: 10.122
Authors: Haoyi Fu; Nicola L Hawley; Jenna C Carlson; Emily M Russell; Alysa Pomer; Hong Cheng; Take Naseri; Muagututi'a Sefuiva Reupena; Ranjan Deka; Courtney C Choy; Stephen T McGarvey; Ryan L Minster; Daniel E Weeks Journal: Obes Res Clin Pract Date: 2022-05-20 Impact factor: 5.214
Authors: Emily M Russell; Jenna C Carlson; Mohanraj Krishnan; Nicola L Hawley; Guangyun Sun; Hong Cheng; Take Naseri; Muagututi'a Sefuiva Reupena; Satupa'itea Viali; John Tuitele; Tanya J Major; Iva Miljkovic; Tony R Merriman; Ranjan Deka; Daniel E Weeks; Stephen T McGarvey; Ryan L Minster Journal: BMJ Open Diabetes Res Care Date: 2022-02